Skip to search formSkip to main contentSkip to account menu

liraglutide

Known as: N²?-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide, Arg34Lys26-(N-?-(?-Glu(N-?-hexadecanoyl)))-GLP-1[7-37], N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide 
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's… 
National Institutes of Health

Related topics

Related topics

15 relations
3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]3 ML liraglutide 6 MG/ML Pen Injector [Victoza]Glucagon-Like Peptide 1In Blood

Broader (2)

Hypoglycemic AgentsIncretins

Narrower (5)

IDegLiraNN 2211SaxendaVictoza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 14806: The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Most Body Mass Index Categories in Type 2 Diabetes: Results…
Objective: Whether cardiorenal benefits of liraglutide and semaglutide are consistent across body mass index (BMI) categories is… 
2017
2017
Beginning with very low dose (0.2mg) liraglutide in indian type 2 diabetic patients appears better tolerated: experience from real life practice
Submit Manuscript | http://medcraveonline.com Keymessages: Clinicians may start with very low dose (0.2mg per day) liraglutide… 
2016
2016
Euglycemic Ketoacidosis Caused by SodiumGlucose Cotransporter 2 Inhibitors: A Case Report
Background: Sodiumglucose cotransporter 2 (SGLT-2) inhibitors decrease blood glucose levels in patients with type 2 diabetes… 
2015
2015
Effect of liraglutide vs. NPH in combination with metformin on blood glucose fluctuations assessed using continuous glucose monitoring in patients with newly diagnosed type 2 diabetes.
BACKGROUND To evaluate the effect of liraglutide and NPH on blood glucose fluctuations in patients with newly diagnosed type 2… 
2015
2015
23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR)
SamenvattingThis 26-week, open-label trial compared the efficacy and safety of IDegLira vs. IG in subjects with type 2 diabetes… 
2015
2015
Liraglutide With or Without Metformin Ameliorates Liver Function and Fatty Liver in Obese Patients with Type 2 Diabetes Mellitus
Objective: To evaluate efficacy of 24 weeks administration of liraglutide with or without metformin on liver parameters, visceral… 
2014
2014
Real-World Clinical Effectiveness of Liraglutide in Individuals 65 Years and Older with Type 2 Diabetes in the United States
Objective: Clinical trials have shown that liraglutide effectively lowers A1C levels and helps manage weight in Type 2 diabetes… 
2013
2013
Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows
People with type 2 diabetes who take exenatide and sitagliptin have double the risk of hospitalisation for acute pancreatitis as… 
2013
2013
Liraglutida reduce biomarcadores y riesgo vascular en pacientes con diabetes mellitus tipo 2
La liraglutida es el primer analogo humano del peptido similar al glucagon tipo 1( GLP-1) que parece mostrar un perfil positivo… 
2010
2010
Incretinas e incretinomiméticos: actualización en liraglutida, una nueva opción terapéutica para pacientes con diabetes mellitus tipo 2